AI Agent Operational Lift for Discovery Research Group, Owned By Ironwood Insights Group in Midvale, Utah

Why AI matters at this scale

Discovery Research Group, a mid-market custom research firm under Ironwood Insights Group, sits at a critical inflection point. With 200–500 employees and a specialization in healthcare and B2B insights, the company faces mounting pressure from both tech-enabled agile platforms and global conglomerates. AI adoption is no longer optional—it is a lever to defend margins, accelerate speed-to-insight, and differentiate on strategic advisory rather than pure data collection. At this size, the firm has sufficient data volume to train or fine-tune models but lacks the sprawling IT bureaucracy of a mega-enterprise, making it an ideal candidate for pragmatic, high-ROI AI deployment.

1. Automating the analysis backbone

The most immediate opportunity lies in automating open-end coding and thematic analysis. Verbatim responses from thousands of physicians or patients currently require manual tagging, a process prone to inconsistency and burnout. Deploying a fine-tuned large language model (LLM) to categorize sentiments and themes can compress weeks of work into hours. The ROI is direct: reduced project labor costs by an estimated 30–40% and faster deliverables that improve client satisfaction and win rates.

2. Generative reporting as a force multiplier

Research analysts spend a significant portion of their time building slide decks and writing summary reports. Generative AI, integrated with data visualization outputs, can produce first-draft executive summaries, complete with narrative arcs and key implications. This shifts the analyst’s role from report assembler to strategic consultant, allowing the firm to handle more projects without proportional headcount growth. For a firm billing by project, this directly increases revenue per employee.

3. Intelligent fieldwork and data quality

AI can monitor survey responses in real time, flagging straight-lining, speeders, or contradictory answers. For healthcare studies where data integrity is paramount, this reduces the costly need for post-hoc data cleaning and re-fielding. Additionally, synthetic data generation can augment hard-to-reach physician panels for early-stage concept tests, reducing sample costs and timelines.

Deployment risks specific to this size band

Mid-market firms face unique hurdles. Budget constraints mean off-the-shelf enterprise AI tools may be priced out, requiring a build-vs-buy evaluation. Data privacy is critical—client-side PII and proprietary product concepts must never leak into public models, necessitating private instances or on-premise deployments. There is also a cultural risk: veteran researchers may distrust AI-generated insights, so a phased rollout with transparent validation steps is essential. Finally, the parent company structure requires alignment across brands to avoid fragmented tooling and to negotiate better vendor pricing.